Transitioning Safely from Intravenous to Subcutaneous Insulin
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
The transition from intravenous (IV) to subcutaneous (SQ) insulin in the hospitalized patient with diabetes or hyperglycemia is a key step in patient care. This review article suggests a stepwise approach to the transition in order to promote safety and euglycemia. Important components of the transition include evaluating the patient and clinical situation for appropriateness, recognizing factors that influence a safe transition, calculation of proper SQ insulin doses, and deciding the appropriate type of SQ insulin. This article addresses other clinical situations including the management of patients previously on insulin pumps and recommendations for patients requiring glucocorticoids and enteral tube feedings. The use of institutional and computerized protocols is discussed. Further research is needed regarding the transition management of subgroups of patients such as those with type 1 diabetes and end-stage renal disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The addition of noninsulin agents, such as DPP-4 inhibitors or GLP-1 RAs, before admission or during the perioperative period, has not reduced rates of stress hyperglycemia and may increase nausea and vomiting rates1316–1324 among critically ill persons.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1320]
In the citing paper
“While the use of these agents is safe and may result in lower glucose levels and insulin doses, we do not recommend addition of a DPP-4 inhibitor or GLP-1 RA to IV insulin therapy until efficacy is demonstrated.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1320]
In the citing paper
“For individuals who are eating but continue to need intravenous insulin infusion, prandial coverage may be provided as rapid-acting insulin administered subcutaneously, as this would prevent large fluctuations in intravenous insulin requirement and subsequent hypoglycemia risk (63).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [63]
In the citing paper
“Successful transition from intravenous to subcutaneous insulin requires administration of basal insulin 2-4 h before the intravenous insulin is stopped to prevent recurrence of ketoacidosis and rebound hyperglycemia while the subcutaneous insulin action rises (63,179).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [63]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 70 · Cited by 36
Research works printed but not linked: 2
- Hemerson P, Banarova A, Izakovic M, et al. Transitioning postoperative cardiovascular surgery patients from intravenous to subcutaneous insulin: an improvement project. J Clin Outcomes Manag JCOM. 2011;18(12):563–7.
- Palazzo A, Smith B, Shoun F, et al. Use of the eGlycemic management system by glytec provides safe and effective transition from iv to subq insulin therapy. Diabetes technology meeting; November 6–8. Diabetes Technology Society: Bethesda; 2014.
Metadata
- Authors
- Kreider, K. E., & Lien, L. F.
- Affiliations
- Duke University (US)
- University of Mississippi Medical Center (US)
- Corresponding author
- Kreider, Kathryn Evans
- Venue
- Current Diabetes Reports
- Published
- 2015-03-15
- Volume
- 15
- Issue
- 5
- Pages
- 23-23
- ISSN
- 1534-4827 (ISSN-L)
- 1539-0829
- OpenAlex
- W1982545756
- Cited by
- 36
- References
- 70
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 3 · 2019: 1 · 2018: 2 · 2017: 6 · 2016: 3 · 2015: 1
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Diabetes Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- hospitalized patients, diabetes mellitus, hyperglycemia, glucocorticoids, enteral nutrition, normoglycemia, type 1 diabetes, end-stage renal disease
- MeSH terms
- Clinical Decision-Making, Dose-Response Relationship, Drug, Humans, Injections, Subcutaneous, Insulin, Blood Glucose Self-Monitoring, Administration, Intravenous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transitioning Safely from Intravenous to Subcutaneous Insulin. https://app.cochat.ai/papers/10.1007/s11892-015-0595-4
- The paper
- Kreider, K. E., & Lien, L. F. (2015). Transitioning Safely from Intravenous to Subcutaneous Insulin. Current Diabetes Reports. https://doi.org/10.1007/s11892-015-0595-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.